References
- Bäärnhielm C., Dahlbäck H., Skånberg I. In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man. Acta Pharmacologica et Toxicologica 1986; 59: 113–122
- Bialer M., Tonelli A. P., Kantrowitz J. D., Yacobi A. Serum protein binding of a new oral cephalosporin, CL284,635, in various species. Drug Metabolism and Disposition 1986; 14: 132–136
- Bischoff K. B., Dedrick R. L., Zaharko D. S., Longstreth J. A. Methotrexate Pharmacokinetics. Journal of Pharmaceutical Sciences 1971; 60: 1128–1133
- Gibaldi M., Perrier D. Pharmacokinetics2nd ed. Marcel Dekker, New York and Basel 1982; 199–208
- Harris P. A., Gross J. F. Preliminary pharmacokinetic model for adriamycin (NSC-123127). Cancer Chemotherapy Reports Part 1 1975; 59: 819–825
- Higuchi S., Shiobara Y. Comparative pharmocokinetics of nicardipine hydrochloride, a new vasodilator, in various species. Xenobiotica 1980; 10: 447–454
- Kohno K., Takeuchi Y., Etoh A., Noda K. Pharmacokinetics and bioavailability of diltiazem (CRD-401) in dog. Arzneimittel-Forschung 1977; 27: 1424–1428
- Lutz R. J., Dedrick R. L., Matthews H. B., Eling T. E., Anderson M. W. A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat. Drug Metabolism and Disposition 1977; 5: 386–396
- Niwa T., Tokuma Y., Noguchi H. The oxidation of nilvadipine to the corresponding pyridine by rat liver microsomes. Xenobiotic Metabolism and Disposition 1986; 1: 304–305
- Ohtsuka M., Ono T., Hiroi J., Esumi K., Kikuchi H., Kumada S. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists. Journal of Cardiovascular Pharmacology 1983; 5: 1074–1082
- Pfeffer M. COMPT, a time-sharing program for nonlinear regression analysis of compartmental models of drug distribution. Journal of Pharmacokinetics and Biopharmaceutics 1973; 1: 137–163
- Terakawa M., Tokuma Y., Shishido A., Noguchi H. Pharmacokinetics of nilvadipine in healthy volunteers. The Journal of Clinical Pharmacology 1987; 27: 111–117
- Terashita S., Tokuma Y., Fujiwara T., Shiokawa Y., Okumura K., Noguchi H. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 1987; 17: 1413–1423
- Tokuma Y., Fujiwara T., Noguchi H. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 1987a; 17: 1339–1347
- Tokuma Y., Fujiwara T., Sekiguchi M., Noguchi H. Determination of nilvadipine in plasma and urine by capillary column gas chromatography with electron capture detection. Journal of Chromatography 1987b; 415: 156–162
- Wagner J. G. Fundamentals of Clinical Pharmacokinetics. Drug Intelligence Publications, Illinois 1975; 288
- Wagner J. G. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. Journal of Pharmacokinetics and Biopharmaceutics 1976; 4: 443–467
- Yamaoka K., Nakagawa T., Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics 1978a; 6: 165–175
- Yamaoka K., Nakagawa T., Uno T. Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 1978b; 6: 547–558